Levodopa-carbidopa intestinal gel: updated GLORIA results


REPORT FROM THE 67TH AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING – WASHINGTON DC, APRIL 18-25, 2015 – The GLORIA non-interventional study recently reported interim results of levodopa-carbidopa intestinal gel (LCIG) in the routine management of patients with advanced Parkinson’s disease (Antonini et al. Parkinsonism Relat Disord 2015;21:231-235).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page